Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis

NCT02534636 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: BMS-986165
DRUG: Interferon alpha-2a recombinant
DRUG: Famotidine
OTHER: Placebo

Sponsor

Bristol-Myers Squibb